Popular pre-market trades in US stocks: Rectitude up 17.30% in pre-market; Scribe Therapeutics up 14.12% in pre-marketPrice Alert·Jul 31 at 05:23 AMRECT-2.39%SCTX+5.88%
Behzad Aghazadeh Holds Board Seat at Scribe Therapeutics with 16.37% StakeTradingView·Jul 30 at 08:36 PMSCTX+5.88%LLY-0.51%
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga_article·Jul 30 at 04:05 PMNUWE+16.77%QURE-0.86%
U.S. stock market midday update: Scribe Therapeutics up 20.75%, OrbiMed increases holdings by 1 million shares boosting confidencePrice Alert·Jul 30 at 12:08 PMSCTX+5.88%
Pre-market hot trades in US stocks: Scribe Therapeutics up 7.95% in pre-market; Marvell Tech up 4.88% in pre-marketPrice Alert·Jul 30 at 07:29 AMSCTX+5.88%MRVL+12.81%
OrbiMed Advisors Discloses Investment in Scribe Therapeutics with 7.2% StakeTradingView·Jul 29 at 05:46 PMSCTX+5.88%
Scribe Therapeutics CFO David Parrot reports $ 39,990 common stock acquisitionPUBT·Jul 27 at 08:21 PMSCTX+5.88%
Scribe Therapeutics adopts amended and restated bylaws effective at IPO closePUBT·Jul 27 at 04:10 PMSCTX+5.88%
U.S. stock market update: Scribe Therapeutics down 12.03%, stock price pressured by clinical delay in gene editingPrice Alert·Jul 27 at 12:14 PMSCTX+5.88%
